Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tobias Limbourg
Use of Vitamin K Antagonists for Secondary Stroke Prevention Depends on the Treating Healthcare Provider in Germany – Results From the German AFNET Registry
BMC Neurology
Medicine
Neurology
Related publications
Patients’ Knowledge and Perspectives on Vitamin K Antagonists for Stroke Prevention in Atrial Fibrillation: Implications for Treatment Quality
Anatolian journal of cardiology
Cardiovascular Medicine
Cardiology
Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Anitplatelet Drugs in the Secondary Prevention of Stroke
Practical Neurology
Medicine
Neurology
Stroke In-Hospital Survival and Its Predictors: The First Results From Tabriz Stroke Registry of Iran
International Journal of General Medicine
Medicine
Risk of Major Bleeding and Stroke Associated With the Use of Vitamin K Antagonists, Nonvitamin K Antagonist Oral Anticoagulants and Aspirin in Patients With Atrial Fibrillation: A Cohort Study
British Journal of Clinical Pharmacology
Pharmacology
Cryptogenic Stroke Prevention Through Venous Thromboembolism Prevention: Potential and Truth in the Advent of Non-Vitamin K Antagonist Oral Anticoagulants
Journal of Cardiology Cases
Cardiovascular Medicine
Cardiology
Secondary Prevention of Ischaemic Stroke
Internal Medicine Journal
Internal Medicine
Use of Cilostazol for Secondary Stroke Prevention: An Old Dog With New Tricks?
Annals of Pharmacotherapy
Medicine
Pharmacology
Role of Non-Vitamin K Oral Anticoagulants for Prevention of Stroke in Renal Impaired Atrial Fibrillation Patients
ACI (Acta Cardiologia Indonesiana)
